These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30057241)
1. Functional characterization of a novel progranulin mutation in a patient with progressive nonfluent aphasia. Gaweda-Walerych K; Sitek EJ; Narożańska E; Wezyk M; Brockhuis B; Zekanowski C; Sławek J Neurobiol Aging; 2018 Dec; 72():186.e9-186.e12. PubMed ID: 30057241 [TBL] [Abstract][Full Text] [Related]
2. One novel GRN null mutation, two different aphasia phenotypes. Coppola C; Oliva M; Saracino D; Pappatà S; Zampella E; Cimini S; Ricci M; Giaccone G; Di Iorio G; Rossi G Neurobiol Aging; 2020 Mar; 87():141.e9-141.e14. PubMed ID: 31837909 [TBL] [Abstract][Full Text] [Related]
3. Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation. Skoglund L; Brundin R; Olofsson T; Kalimo H; Ingvast S; Blom ES; Giedraitis V; Ingelsson M; Lannfelt L; Basun H; Glaser A Neurogenetics; 2009 Feb; 10(1):27-34. PubMed ID: 18855025 [TBL] [Abstract][Full Text] [Related]
4. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice. Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904 [TBL] [Abstract][Full Text] [Related]
5. Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation. Canu E; Bessi V; Leocadi M; Padiglioni S; Nacmias B; Sorbi S; Filippi M; Agosta F J Neurol; 2019 May; 266(5):1274-1279. PubMed ID: 30923936 [TBL] [Abstract][Full Text] [Related]
6. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers. Alquézar C; Esteras N; de la Encarnación A; Alzualde A; Moreno F; López de Munain A; Martín-Requero A Neurobiol Aging; 2014 Apr; 35(4):886-98. PubMed ID: 24139281 [TBL] [Abstract][Full Text] [Related]
7. Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation. Caso F; Agosta F; Magnani G; Galantucci S; Spinelli EG; Galimberti D; Falini A; Comi G; Filippi M J Neurol Sci; 2014 Jul; 342(1-2):167-72. PubMed ID: 24814951 [TBL] [Abstract][Full Text] [Related]
8. Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma. Miyagawa T; Ichimura Y; Nakamura K; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Taniguchi T; Akamata K; Yoshizaki A; Sato S; Asano Y J Dermatol Sci; 2018 Nov; 92(2):207-214. PubMed ID: 30268392 [TBL] [Abstract][Full Text] [Related]
9. Progranulin deficiency leads to reduced glucocerebrosidase activity. Zhou X; Paushter DH; Pagan MD; Kim D; Nunez Santos M; Lieberman RL; Overkleeft HS; Sun Y; Smolka MB; Hu F PLoS One; 2019; 14(7):e0212382. PubMed ID: 31291241 [TBL] [Abstract][Full Text] [Related]
10. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Borroni B; Alberici A; Premi E; Archetti S; Garibotto V; Agosti C; Gasparotti R; Di Luca M; Perani D; Padovani A Rejuvenation Res; 2008 Jun; 11(3):585-95. PubMed ID: 18593276 [TBL] [Abstract][Full Text] [Related]
11. Progranulin as a therapeutic target for dementia. Galimberti D; Fenoglio C; Scarpini E Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573 [TBL] [Abstract][Full Text] [Related]
12. Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity. Valdez C; Ysselstein D; Young TJ; Zheng J; Krainc D Hum Mol Genet; 2020 Mar; 29(5):716-726. PubMed ID: 31600775 [TBL] [Abstract][Full Text] [Related]
13. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611 [TBL] [Abstract][Full Text] [Related]
14. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort. Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032 [TBL] [Abstract][Full Text] [Related]
15. The lysosomal function of progranulin, a guardian against neurodegeneration. Paushter DH; Du H; Feng T; Hu F Acta Neuropathol; 2018 Jul; 136(1):1-17. PubMed ID: 29744576 [TBL] [Abstract][Full Text] [Related]
19. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review. Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852 [TBL] [Abstract][Full Text] [Related]